Cite
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
MLA
Ferreri, Andrés J. M., et al. “MATRix-RICE Therapy and Autologous Haematopoietic Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma with Secondary CNS Involvement (MARIETTA): An International, Single-Arm, Phase 2 Trial.” The Lancet. Haematology, vol. 8, no. 2, Feb. 2021, pp. e110–21. EBSCOhost, https://doi.org/10.1016/S2352-3026(20)30366-5.
APA
Ferreri, A. J. M., Doorduijn, J. K., Re, A., Cabras, M. G., Smith, J., Ilariucci, F., Luppi, M., Calimeri, T., Cattaneo, C., Khwaja, J., Botto, B., Cellini, C., Nassi, L., Linton, K., McKay, P., Olivieri, J., Patti, C., Re, F., Fanni, A., … Cwynarski, K. (2021). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. The Lancet. Haematology, 8(2), e110–e121. https://doi.org/10.1016/S2352-3026(20)30366-5
Chicago
Ferreri, Andrés J M, Jeanette K Doorduijn, Alessandro Re, Maria Giuseppina Cabras, Jeffery Smith, Fiorella Ilariucci, Mario Luppi, et al. 2021. “MATRix-RICE Therapy and Autologous Haematopoietic Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma with Secondary CNS Involvement (MARIETTA): An International, Single-Arm, Phase 2 Trial.” The Lancet. Haematology 8 (2): e110–21. doi:10.1016/S2352-3026(20)30366-5.